JP4907705B2 - Reagent for urine red blood cell analysis - Google Patents

Description

The present invention relates to a reagent for analyzing erythrocytes in urine, and more particularly, the erythrocytes appeared in the urine, specific for more improved was the urine erythrocytes analysis the determination accuracy of the bacteria such as yeast-like fungus It relates to reagents.

  Analyzing erythrocytes, leukocytes, epithelial cells, cylinders, bacteria, and other particles appearing in urine is important for discriminating diseases of the kidney and urinary tract. For example, red blood cells are important in determining the presence or absence of bleeding in the path from the glomeruli of the kidney to the urethra. An increase in white blood cells indicates suspicion of inflammation or infection. Moreover, the origin site | part can also be estimated by investigating the form of a red blood cell or a cylinder.

  Conventionally, as a method for analyzing particles appearing in urine, a method is used in which a stained urine sample is placed on a slide glass or a calculation board and observed with a microscope, and particles in the visual field are counted for each type. It was done. However, this method is a so-called technique, which not only imposes a burden on the practitioner but also tends to cause variations in counting results depending on the skill level of the practitioner.

  In recent years, a technique for automatically classifying and counting particles contained in urine using a flow cytometry method has been developed. In this method, a sample solution prepared by subjecting a urine sample to fluorescent staining is passed through a flow cell, and the flow cell is irradiated with laser light. Then, the intensity of the forward scattered light and the fluorescence emitted by the particles in the sample liquid irradiated with the laser light are detected. The intensity of the forward scattered light reflects the size of the particle. The larger the particle, the greater the intensity of the forward scattered light. The intensity of fluorescence reflects the degree of fluorescence staining of the particles. Since the forward scattered light intensity and the fluorescence intensity differ depending on the type of particle, the type of particle can be discriminated and counted by combining and analyzing these optical information (see Patent Document 1).

  However, in the method of Patent Document 1, in urine specimens containing yeast-like fungi that are relatively large bacteria, the intensity of forward scattered light and fluorescence detected from those particles are the same as those detected from red blood cells. In some cases, it was difficult to distinguish from red blood cells.

  To solve such a problem, for example, for a specimen in which red blood cells and yeast-like fungi have appeared, a cell membrane damaging agent for hemolyzing red blood cells was added to prepare a sample solution and measured with a flow cytometer. In addition, there is a technique for preparing a sample solution without adding a cell membrane damaging agent, obtaining a result measured by a flow cytometer, and comparing both results to distinguish and count erythrocytes and yeast-like fungi (Patent Document) 2).

US Pat. No. 5,325,169 JP-A-9-329569

  However, in the method described in Patent Document 2, since a sample in which red blood cells are hemolyzed and a sample in which red blood cells are not hemolyzed are measured, the amount of specimens and reagents necessary for the measurement increases, and the time required for the measurement also increases. It will increase.

In view of the above problems, the present invention provides a urine red blood cell analysis reagent that can more efficiently discriminate red blood cells in a specimen. The present invention also provides a urine red blood cell analysis reagent capable of more accurately discriminating red blood cells in a specimen.

The present invention is a reagent for analyzing erythrocytes in urine, from the group consisting of benzyl alcohol, phenol, 1-phenoxy-2-propanol, 2-phenoxyethanol, phenyl acetate, 2-aminobenzothiazole and benzothiazole. There is provided a reagent for analyzing urine erythrocytes , which comprises a first reagent containing a nonionic organic compound having a selected benzene ring and a second reagent containing a fluorescent dye.

The present invention is also a reagent for analyzing red blood cells in urine, and comprises benzyl alcohol, phenol, 1-phenoxy-2-propanol, 2-phenoxyethanol, phenyl acetate, 2-aminobenzothiazole and benzothiazole. A reagent for analyzing urinary red blood cells , comprising a nonionic organic compound having a benzene ring selected from the group and a fluorescent dye is provided.

  According to the present invention, it is possible to discriminate erythrocytes more efficiently than in the prior art by not causing hemolysis of erythrocytes and improving the fluorescence stainability of yeast-like fungi even in specimens in which yeast-like fungi have appeared. It becomes. Further, according to the present invention, it is possible to discriminate red blood cells with higher accuracy.

It is a figure which illustrates typically the two-dimensional scattergram obtained in a conventional method. It is a figure which illustrates typically the two-dimensional scattergram obtained using the reagent of one Embodiment of this invention. It is a figure explaining the external appearance of the particle | grain analyzer in urine . It is a figure explaining the internal structure of the particle | grain analyzer in urine . It is a figure explaining the sample preparation part of the particle | grain analyzer in urine . It is a figure explaining the detection part of the particle | grain analyzer in urine . It is a figure explaining the control part of the particle | grain analyzer in urine . It is a flowchart explaining the whole control of the urine particle | grain analyzer. It is a flowchart explaining the operation | movement of the particle | grain signal analysis of the particle | grain analyzer in urine. It is a flowchart explaining each step of the analysis program performed by the urine particle | grain analyzer. It is a figure which shows an example of the two-dimensional scattergram produced by the urine particle | grain analyzer. It is a figure which shows a mode that the result of the analysis was displayed on the liquid crystal touch panel of the urine particle | grain analyzer. It is a figure which shows an example of the two-dimensional scattergram produced by the urine particle | grain analyzer.

  Hereinafter, embodiments of the present invention will be described. However, the present invention is not limited to this embodiment. In this embodiment, a sample solution is prepared by mixing a urine sample and a predetermined reagent and fluorescently staining particles in the urine. Then, information reflecting the size of the particle and information reflecting the degree of staining of the particle are detected from each particle contained in the sample liquid. Then, by analyzing such information, red blood cells are discriminated from other particles and counted.

  As a method for detecting information that reflects the size of particles and information that reflects the degree of staining of particles, for example, a flow cytometry method can be used. An apparatus that automatically performs this is a flow cytometer. A flow cytometer receives a scattered light and fluorescence emitted from particles in a flow cell for flowing a sample liquid, a laser light source for irradiating the sample liquid flowing in the flow cell with laser light, and a sample liquid irradiated with the laser light. And a signal processing circuit that extracts the signal intensity of the electrical signal for each particle output from the photoelectric conversion element that converts the electrical signal according to the intensity of light. The intensity of the scattered light emitted by the particles is information reflecting the size of the particles, and the intensity of the fluorescence emitted by the particles is information reflecting the degree of fluorescent staining of the particles. The scattered light is scattered in the direction of extension of the optical axis of the laser light incident on the particle or in the peripheral direction (forward scattered light), or the direction orthogonal to the optical axis of the laser light incident on the particle. Or the thing scattered in the peripheral direction (side scattered light), or the thing scattered to other angles is mentioned. These can be used as information reflecting the size of the particles, but forward scattered light is particularly preferably used.

  A so-called electric resistance detector may be used to detect information that reflects the size of the particles. In an electric resistance type detector, particles are passed through a pore to which a voltage is applied, and a change in electric resistance at that time is captured as an electric signal. Since the signal intensity varies depending on the size (volume) of the particle, it can be used as information reflecting the size of the particle.

  If the range of the fluorescence intensity of erythrocytes and the intensity of scattered light (or the intensity of the electrical signal for each particle detected by an electrical resistance detector) is determined in advance, the signal detected from each particle falls within that range. Whether or not the particle is a red blood cell can be determined.

  Reagents for preparing a sample liquid by mixing with a specimen include a staining liquid containing a fluorescent dye for staining particles in a urine specimen, and a substance for preparing an environment for subjecting the specimen to a fluorescent staining treatment Diluents can be used. A sample solution for analysis is prepared by mixing the specimen, the diluent, and the staining solution.

  As described above, when yeast-like fungi appear in urine specimens, the intensity of forward scattered light and fluorescence detected from yeast-like fungus overlaps with the intensity detected from red blood cells, which may be difficult to distinguish. It is. Therefore, if the diluted solution contains a substance that causes a difference in the dyeability of fluorescent dyes between yeast-like fungi and erythrocytes, the fluorescence intensity detected from yeast-like fungi and erythrocytes will differ, and erythrocytes will be discriminated. Accuracy can be improved. Examples of such substances include substances that damage the cell membrane of yeast-like fungi and enhance the permeability of the dye to the inside of the cells. If there is no damage to the cell membrane of the yeast-like fungus, the fluorescent dye will only bind to the cell membrane surface. However, if the cell membrane is damaged, the fluorescent dye will enter not only the cell membrane surface but also the inside of the cell. Binds to internal substances and improves fluorescence staining. It should be noted that a substance that damages the cell membrane of yeast-like fungus and enhances the permeability of the dye to the inside of the cell must be one that does not damage the cell membrane of erythrocytes. This is because if the cell membrane of erythrocytes is damaged, hemolysis occurs, making it difficult to count erythrocytes. Examples of substances that satisfy the above conditions include nonionic organic compounds having a benzene ring. For example, aromatic alcohols such as benzyl alcohol, β-phenethyl alcohol, phenol, 1-phenoxy-2-propanol, and 2-phenoxyethanol, phenyl acetate, and benzothiazole compounds such as 2-aminobenzothiazole and benzothiazole may be used. I can do it. Of these, 2-phenoxyethanol is particularly preferably used.

  In addition, in order to improve the solubility of said each substance, you may contain surfactant, such as MTAB, DTAB, and OTAB, in a dilution liquid. In addition, since there exists a possibility that erythrocytes may be hemolyzed when the density | concentration of the said surfactant is high, it is preferable to use at the density | concentration of the grade which does not hemolyze erythrocytes.

  The diluent preferably contains a buffer or an osmotic pressure compensator in order to maintain buffer capacity within the osmotic pressure and pH ranges where red blood cells do not hemolyze. The pH of the diluted solution is 7.0 to 9.0, preferably 7.1 to 8.6, more preferably 7.1 to 7.8, and still more preferably 7.3 to 7.8. desirable. This is because red blood cells may be hemolyzed when the pH of the diluted solution exceeds 9.0, and in the acidic region, the pH change in the urine specimen is large, and the red blood cells are damaged or the particles in the urine are damaged. This is because the dyeability may be lowered as a whole.

  A conventionally well-known thing can be used as a buffering agent contained in a dilution liquid. For example, Good buffer such as Tris and MES, Bis-Tris, ADA, PIPES, ACES, MOPSO, BES, MOPS, TES, HEPES, DIPSO, TAPSO, POPSO, HEPPSO, EPPS, Tricine, Bicine, TAPS, etc. be able to. Of these, HEPES is preferable. The concentration is used at a concentration at which the pH falls within a certain range when the urine sample is diluted according to the buffering capacity of the buffer used. Usually, it is 20-500 mM, Preferably it is 50-200 mM.

  As the osmotic pressure compensator to be contained in the diluted solution, inorganic salts, organic salts such as propionate, saccharides and the like are used. As the inorganic salts, sodium chloride, potassium chloride, sodium bromide and the like are used. Among the organic salts, as propionate, sodium propionate, potassium propionate, ammonium propionate and the like are used. As other organic salts, oxalate, acetate and the like are used. As the saccharide, sorbitol, glucose, mannitol and the like are used. The osmotic pressure compensating agent is added for the purpose of preventing hemolysis of erythrocytes and obtaining stable fluorescence intensity. The osmotic pressure of urine is distributed over a wide range of 50 to 1300 mOsm / kg. If the osmotic pressure of the analytical reagent is too low, hemolysis of erythrocytes proceeds at an early stage, and conversely if too high, damage to particles in the urine increases, so the osmotic pressure is preferably from 100 to 600 mOsm / kg, and from 150 to 500 mOsm / kg is more preferable.

  Further, in order to reduce the influence of amorphous salts appearing in urine (for example, ammonium phosphate, magnesium phosphate, calcium carbonate), a chelating agent for dissolving them may be contained in the diluent. The chelating agent is not particularly limited as long as it is a decalcifying agent or a demagnesizing agent. Examples thereof include EDTA salts, CyDTA, DHEG, DPTA-OH, EDDA, EDDP, GEDTA, HDTA, HIDA, Methyl-EDTA, NTA, NTP, NTPO, EDDPO, and the like. Preferably, EDTA salt, CyDTA or GEDTA is used. The concentration can be used in the range of 0.05 to 5 W / W%, and preferably 0.1 to 1 W / W%. In addition, a decalcification agent and a demagnetization agent here mean what bind | bond | couples with calcium ion and magnesium ion, and forms a water-soluble compound.

  As a fluorescent dye for staining particles contained in urine, for example, a condensed benzene derivative represented by the following chemical formula can be used.

[Wherein, A is —O—, —S— or —C (CH ₃ ) ₂ —, R is a lower alkyl group, X is halogen, Y is —CH═ or —NH—, n is 0 or 1, B Is

(Wherein A and R are as defined above) or a phenyl group substituted with two lower alkoxy groups or one di-lower alkylamino group (this lower alkyl may be substituted with a cyano group). . ]. The lower alkyl group means an alkyl group having 1 to 6 carbon atoms, and examples thereof include methyl, ethyl, propyl, butyl, isobutyl, pentyl, hexyl and the like. Examples of the halogen atom for X include fluorine, chlorine, bromine and iodine. The phenyl group substituted with two lower alkoxy groups in B refers to a phenyl group substituted with two C _1-3 alkoxy groups, preferably C _1-2 alkoxy groups such as a methoxy group and an ethoxy group. . Specific examples include a 2,6-dimethoxyphenyl group and a 2,6-diethoxyphenyl group. The phenyl group substituted with a di-lower alkylamino group in B (the lower alkyl group may be substituted with a cyano group) is a C _1-3 alkylamino group, preferably a C _1-2 alkylamino group. A phenyl group substituted with a group. Here, the alkyl group may be substituted with a cyano group, and includes, for example, methyl, ethyl, cyanomethyl, cyanoethyl and the like. Examples of the phenyl group substituted with a preferred di-lower alkylamino group (which may be substituted with a cyano group) include 4-dimethylaminophenyl group, 4-diethylaminophenyl group, 4- (cyanoethylmethylamino) A phenyl group etc. are mentioned. As a specific example of such a condensed benzene derivative,

Is mentioned. This dye can be obtained from Nippon Sensitive Dye Research Laboratories.

  The dye is a polymethine-based fluorescent dye, and fluorescence is excited by irradiation with red laser light having a wavelength of 633 nm. In addition to the above, the fluorescent dye contained in the staining solution can be appropriately selected and used in accordance with the wavelength of the laser beam for exciting the fluorescence.

  Since many fluorescent dyes are unstable in an aqueous solution, the storage stability of the fluorescent dye can be enhanced by using a fluorescent dye dissolved in a water-soluble organic solvent as a staining solution. As the water-soluble organic solvent, lower alkanol, lower alkylene glycol or lower alkylene glycol mono-lower alkyl ether is preferable. For example, methanol, ethanol, n-propanol, ethylene glycol, diethylene glycol, triethylene glycol, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, or the like can be used. Among them, ethylene glycol, diethylene glycol, and triethylene glycol are preferable, and ethylene glycol is more preferable in consideration of influence on particles in urine and viscosity. The fluorescent dye is desirably used in the range of 1 to 20 ppm, preferably 3 to 12 ppm, more preferably 3 to 9 ppm as the final concentration of the sample solution for analysis.

  Instead of using the dyeing solution and the diluting solution as separate solutions, a fluorescent dye may be contained in the diluting solution and used as a one-component reagent.

  FIG. 1 and FIG. 2 are schematic diagrams showing two-dimensional scattergrams with the forward scattered light intensity and the fluorescence intensity for each particle obtained from a urine sample solution containing red blood cells and yeast-like fungi by a flow cytometer. In both cases, the vertical axis represents the forward scattered light intensity, and the horizontal axis represents the fluorescent intensity. The forward scattered light intensity increases as it goes upward in this coordinate space, and the fluorescent intensity increases as it goes to the left. The red blood cell counting region R is for counting particles having forward scattered light intensity and fluorescence intensity within the range as red blood cells. In each figure, a group of dots corresponding to red blood cells is included in the red blood cell counting region R. Has appeared. The population of dots corresponding to yeast-like fungi is also shown in each figure.

  FIG. 1 shows a two-dimensional scattergram obtained from a urine sample solution prepared by a conventional method. A part of dots corresponding to a yeast-like fungus is in the red blood cell counting region R. In such a case, the red blood cell count result is larger than the actual count, and it is difficult to obtain an accurate red blood cell count.

  On the other hand, FIG. 2 shows a two-dimensional scattergram obtained from a urine sample solution prepared by the method of the present invention. It can be seen that the position where the dot corresponding to the yeast-like fungus moves to the left compared to FIG. 1 (the position in FIG. 1 is indicated by a broken line) and does not overlap with the red blood cell counting region R. This is because the intensity of fluorescence detected from the yeast-like fungus increases due to the action of the substance that improves the dyeability of the yeast-like fungus. Since this substance does not damage the cell membrane of red blood cells, there is no inconvenience in detection and counting of red blood cells.

Example 1
Examples of the present invention will be described below. In this embodiment, human urine is used as a specimen, and urine red blood cells are detected by a urine particle analyzer using flow cytometry.

Sample In this example, a sample obtained by adding purely cultured yeast-like fungus (C. glabrata) at a concentration of about 100 cells / μl to human urine containing red blood cells was used.

Reagent As a reagent used in the urine particle analyzer, a staining solution and a dilution solution having the following composition were used.
Staining solution A staining solution was prepared by dissolving a fluorescent dye represented by the following formula in ethylene glycol so that the final concentration of the analysis sample was 6 ppm.

Diluent A solution obtained by dissolving the following substances in purified water was used as a dilute solution.
HEPES ... 11.9 g / l
Sodium propionate ... 5.98 g / l
EDTA-3K ... 4.0 g / l
2-phenoxyethanol ... 7.5g / l
Sodium hydroxide: the amount that makes the pH 7.0

Urinary Particle Analyzer FIG. 3 shows the appearance of the urine particle analyzer 100 used in this embodiment. The front surface of the apparatus is provided with a liquid crystal touch panel 101 for inputting various settings and displaying and outputting analysis results, a cover 102 covering a sample preparation unit 200 described later, and a start switch 103. FIG. 4 shows the internal configuration of the urine particle analyzer 100. In the space on the right side of the apparatus, a control unit 400 that controls the operation and analysis processing of the apparatus is provided. A detection unit 300 for detecting a signal from the sample solution is provided in the lower left space of the apparatus. In the remaining space, a sample preparation unit 200 for preparing a sample solution is provided.

  Hereafter, each part of the sample preparation part 200, the detection part 300, and the control part 400 is demonstrated.

Configuration of Sample Preparation Unit 200 FIG. 5 is an explanatory diagram showing the sample preparation unit 200. The sample preparation unit 200 includes a sample setting unit 221 on the front right side, a reagent setting unit 222 on the front left side, and an incubator 223 on the back side. A dispensing device 224 is also provided. When the operator opens the cover 102 of FIG. 3, the sample preparation unit 200 shown in FIG. 5 appears. In the sample preparation unit 200, the sample setting unit 221 is configured to set a sample container 225 containing a sample. A reaction vessel 226 is set in the incubator 223. The reagent setting unit 222 is configured to set a reagent container 227 containing a staining liquid and a reagent container 231 containing a diluent. The incubator 223 is configured to shake and agitate the liquid in the set reaction vessel 226 while maintaining a predetermined temperature. The dispensing device 224 sucks and discharges a predetermined amount of liquid from its tip, and is configured to be movable back and forth, up and down, and left and right by a driving device (not shown). The sample container 233 is connected to a flow cell 301 of the detection unit 300 described later.

Configuration of Detection Unit 300 FIG. 6 is an explanatory diagram showing the configuration of the detection unit 300. The detection unit 300 includes a flow cell 301 for flowing a sample solution. The flow cell 301 is a portion irradiated with laser light and has an orifice portion 302 whose internal flow path is narrowed, a nozzle 303 for injecting a sample liquid upward toward the orifice portion, a sheath liquid supply port 304, and a drain port. 305. The detection unit 300 includes a laser light source 306 for irradiating laser light. The laser light source 306 is a red semiconductor laser light source that emits laser light having a wavelength of 633 nm. The semiconductor laser light source is advantageous in that it is smaller than a conventional gas laser light source represented by an argon ion laser light source and has a long oscillation lifetime. The detection unit 300 further receives a condenser lens 307 that condenses the laser light emitted from the laser light source 306 onto the flow cell 301, and forward-scattered light emitted from particles in the sample liquid irradiated with the laser light to receive an electrical signal. A photodiode 308 for converting the light into a collector lens 309 and a pinhole 310 for condensing the forward scattered light to the photodiode 308, and receiving an electric signal by receiving fluorescence emitted from particles in the sample liquid irradiated with the laser light. The photomultiplier tube 311 to be converted into the photomultiplier tube, the collector lens 312 for condensing the fluorescence to the photomultiplier tube 311, the filter 313, the pinhole 314, the electric signal output from the photodiode 308 and the photomultiplier tube 311 is amplified. Control as forward scattered light signal and fluorescence signal An amplifier 315 and 316 to be output to 400.

Configuration of Control Unit 400 FIG. 7 is a block diagram showing the configuration of the control unit 400 and the relationship between the control unit 400 and each unit of the apparatus. The control unit 400 is a memory 401, a central processing unit (CPU) 402, a signal processing circuit 403 that processes a signal sent from the detection unit 300, and an operation for controlling the operation of each unit of the urine particle analyzer 100. A control circuit 404 is included. The memory 401 stores an analysis program relating to analysis of signals obtained from particles such as red blood cells and bacteria contained in the sample solution, and a control program for controlling the operation of each part of the apparatus. Further, the data processed by the signal processing circuit 403 and the processing result by the analysis program are stored. The CPU 402 executes an analysis program and a control program read from the memory 401, processes and analyzes signals detected from the sample solution in the detection unit 300, and controls signals for controlling operations of the respective units of the apparatus. Or sent to the circuit 404. An analysis result by the analysis program is output to the liquid crystal touch panel 101.

  Hereinafter, the details of the operation of the urine particle analyzer 100 will be described. FIG. 8 is a flowchart showing overall control of the urine particle analyzer 100 by the control program. When the operator presses the start switch 103, the control program is activated, and step S1 (preparation of the sample solution for analysis), step S2 (detection of the particle signal), and step S3 (analysis of the particle signal) are sequentially executed. Thereby, each part of the sample preparation part 200, the detection part 300, and the control part 400 is controlled, and a series of operation | movement of the particle | grain analysis apparatus 100 in urine is performed automatically. The operation of each part of the apparatus in steps S1, S2, and S3 will be described below.

Step S1 (Preparation of sample solution for analysis)
In step S1, the sample preparation unit 200 is controlled to prepare an analysis sample. The operation of the sample preparation unit 200 in step S1 will be described with reference to FIG. First, the dispensing device 224 sucks 522 μL of the diluent from the reagent container 231 of the reagent setting unit 222, and then sucks 180 μL of the sample (human urine) from the sample container 225 set in the sample setting unit 221. Then, the aspirated diluted solution and the specimen are dispensed into the reaction vessel 226 set in the incubator 223. Next, the dispensing device 224 sucks 18 μL of the staining solution from the reagent container 227 of the reagent setting unit 222 and dispenses it into the reaction container 226. Thereafter, the incubator 223 agitates for 10 seconds while keeping the liquid temperature in the reaction vessel 226 containing the specimen, dilution liquid, and staining liquid at 35 ° C., and stains the diluted specimen. The sample solution for analysis thus prepared is sucked by the dispensing device 224 and supplied to the sample container 233. The sample liquid for analysis supplied to the sample container 233 is flowed to the flow cell 301 of the detection unit 300.

Step S2 (particle signal detection)
In step S2, the detection unit 300 is controlled to detect a signal that reflects the characteristics of each particle from the particles in the sample liquid for analysis. The operation of the detection unit 300 in step S2 will be described with reference to FIG. As described above, when the sample solution is supplied to the sample container 233, the sample solution is guided to the nozzle 303 by the operation of a pump or a valve (not shown). Then, the sample liquid is discharged from the nozzle 303 to the flow cell 301. At the same time, the sheath liquid is supplied to the flow cell 301 through a sheath liquid supply port 304 from a sheath liquid container (not shown). As a result, the sample liquid is wrapped in the sheath liquid in the flow cell 301 and further squeezed by the orifice 302 and flows. By narrowing down the flow of the sample solution, particles such as red blood cells and bacteria contained in the sample solution can be aligned and flow through the orifice part 302. Laser light emitted from the laser light source 306 is squeezed by the condenser lens 307 and irradiated to the sample liquid flowing through the orifice portion 302. The forward scattered light emitted from the particles in the sample liquid that has received the laser light is collected by the collector lens 309. The forward scattered light that has passed through the pinhole 310 is received and photoelectrically converted by the photodiode 308 to become a pulsed forward scattered light signal. The fluorescence emitted from the particles in the sample liquid that has received the laser light is collected by the collector lens 312. The fluorescence that has passed through the filter 313 and the pinhole 314 is received and photoelectrically converted by the photomultiplier tube 311 to become a pulsed fluorescence signal. The forward scattered light signal and the fluorescence signal are respectively amplified by the amplifiers 315 and 316 and sent to the control unit 400.

Step S3 (particle signal analysis)
The forward scattered light signal and the fluorescence signal detected by the detection unit 300 in step S2 are analyzed by the control unit 400 according to the flow shown in FIG. 9 (steps S31 to S34).

Step S31: First, the forward scattered light signal and the fluorescence signal detected by the detection unit 300 are input to the signal processing circuit 403. For each of the forward scattered light signal and the fluorescence signal, the signal processing circuit 403 regards a portion exceeding a predetermined signal intensity in a series of signal waveforms as a signal in which particles are detected. Then, the peak value of the signal intensity is extracted for each particle. The peak value of the forward scattered light signal is the forward scattered light intensity, and the peak value of the fluorescent signal is the fluorescent intensity.

Step S32: The forward scattered light intensity and the fluorescence intensity obtained in step S31 are stored in the memory 401 as data for each particle.

Step S <b> 33: The data of the forward scattered light intensity and the fluorescence intensity for each particle stored in the memory 401 are analyzed by an analysis program stored in advance in the memory 401. Each step of the analysis program read and executed by the CPU 402 will be described with reference to the flowchart of FIG.

Step S331: Data of forward scattered light intensity and fluorescence intensity corresponding to each particle in the analysis sample is acquired from the memory 401.

Step S332: The data of the forward scattered light intensity and the fluorescence intensity are developed in a two-dimensional coordinate space, and a two-dimensional scattergram using the forward scattered light intensity and the fluorescence intensity as parameters is created.

Step S333: The red blood cell counting region R is set on the two-dimensional scattergram created in step S332. The red blood cell counting area R is an area set for counting particles having forward scattered light intensity and fluorescent intensity within the range as red blood cells. The coordinate data of the red blood cell counting region R is stored in advance in the memory 401, and is read out by the analysis program in this step and applied to the two-dimensional scattergram. The position of the red blood cell counting region R is determined based on the forward scattered light intensity and fluorescence intensity obtained from particles in urine that have been confirmed to be red blood cells by microscopic examination or the like.

  An example of the two-dimensional scattergram created in step S333 is shown in FIG. In this two-dimensional scattergram, the vertical axis represents the forward scattered light intensity, and the horizontal axis represents the fluorescence intensity. In this coordinate space, the intensity of forward scattered light increases as it goes upward, and the intensity of fluorescence increases as it goes left. The red blood cell counting region R is set. In addition, dots corresponding to each particle in the sample solution appear on the two-dimensional scattergram.

Step S334: Count the number of dots appearing in the red blood cell counting region R. The number of red blood cells contained per unit amount of the sample is calculated based on the number of dots, the dilution rate of the sample in the preparation of the sample for analysis, and the volume of the sample solution passed through the flow cell.

Step S335: Data for outputting the created two-dimensional scattergram and the red blood cell count result as an analysis result to the liquid crystal touch panel 101 is created, and the created data is stored in the memory 401. The above is the step executed by the analysis program in step S33. Subsequently, the process proceeds to step S34 in the flow shown in FIG.

Step S34:
In step S 335, the analysis result data stored in the memory 401 is output to the liquid crystal touch panel 101. FIG. 12 is a schematic diagram showing how the data is output to the liquid crystal touch panel 101. On the liquid crystal touch panel 101, the two-dimensional scattergram and the red blood cell count are displayed as analysis results.

Example of Analysis Results FIG. 11 is a two-dimensional scattergram obtained by analyzing the specimen with the urine particle analyzer 100. The vertical axis represents the forward scattered light intensity, and the horizontal axis represents the fluorescent intensity. The forward scattered light intensity increases toward the upper side in this coordinate space, and the fluorescent intensity increases toward the left. The red blood cell counting area R is an area set for counting particles having forward scattered light intensity and fluorescence intensity within the range as red blood cells, and a group of dots corresponding to red blood cells appears in that area. is doing. On the other hand, it can be seen that the group of dots corresponding to the yeast-like fungus does not enter the red blood cell counting region R.

Example 2
As a control for Example 1, a urine sample was analyzed using a diluent having the following composition in the urine particle analyzer 100. This diluted solution differs from that used in Example 1 in that it does not contain 2-phenoxyethanol. The specimen, staining solution, and urine particle analyzer used are the same as in Example 1.
Diluent A solution obtained by dissolving the following substances in purified water was used as a dilute solution.
HEPES ... 11.9 g / l
Sodium propionate ... 5.98 g / l
EDTA-3K ... 4.0 g / l
Sodium hydroxide: the amount that makes the pH 7.0

  FIG. 13 shows a two-dimensional scattergram obtained in this example. In this figure, it can be seen that a part of the group of dots corresponding to the yeast-like fungus is in the red blood cell counting region R. When this Example 2 is compared with Example 1 above, in Example 1, 2-phenoxyethanol acts on the yeast-like fungus in the sample to increase the permeability of the dye, and the yeast-like fungus is larger than the erythrocytes. It seems that it came to have fluorescence intensity.

Example 3
The content of sodium hydroxide in the diluted solution used in Example 1 was changed to prepare four types of diluted solutions having different pHs. These were designated as diluents 1 to 5 having different pH levels including the diluent used in Example 1 (Diluent 1: pH 7.0, Diluent 2: pH 7.1, Diluent 3: pH 7.3). Diluent 4: pH 7.8, Diluent 5: pH 8.6). Urine samples were analyzed using these dilutions. The specimen used was a human urine containing no red blood cells with a purely cultured yeast-like fungus (C. glabrata) added at a concentration of about 100 cells / μl. The staining solution and urine particle analyzer used are the same as in Example 1. And in the analysis using each dilution liquid, the average value of the fluorescence signal intensity obtained from the yeast-like fungus was calculated. The results are shown in Table 1 below. The fluorescence intensity value is a relative value when the minimum value on the horizontal axis is 0 and the maximum value is 255 in the two-dimensional scattergram obtained by the urine particle analyzer 100 shown in FIGS. is there.

  In Table 1, when the pH of the diluted solution is in the range from neutral to weakly alkaline such as 7.0 to 8.6, the fluorescence staining property of the yeast-like fungus is improved as the alkalinity increases. Therefore, by selecting a pH at which the fluorescence staining property of the yeast-like fungus is improved and the difference in fluorescence intensity from the erythrocytes is increased, the discrimination between the two becomes more reliable.

Example 4
In the diluent used in Example 1, a diluent using another substance was prepared instead of 2-phenoxyethanol, which was contained as a substance that acts on yeast-like fungi to enhance the permeability of the pigment. Urine samples were analyzed using these dilutions. The specimen, staining solution, and urine particle analyzer used are the same as in Example 3. And in the analysis using each dilution liquid, the average value of the fluorescence signal intensity obtained from the yeast-like fungus was calculated. Table 2 below shows the names of substances contained in the diluent instead of 2-phenoxyethanol and the average value of the fluorescence signal intensity obtained from the yeast-like fungus. The concentration of each substance in the diluted solution is 1.0 wt%. The fluorescence intensity value is the same as in Example 3 when the minimum value on the horizontal axis in the two-dimensional scattergram obtained by the urine particle analyzer 100 shown in FIGS. 11 and 13 is 0 and the maximum value is 255. It is a relative value.

  In addition, according to the experiments by the present inventors, the fluorescence signal intensity obtained from the yeast-like fungus was used when a diluent that does not contain a substance that improves the fluorescent staining property of the yeast-like fungus as listed in Table 2 was used. The average value of was about 20-50. Therefore, it can be seen that the fluorescent staining property of the yeast-like fungus is greatly improved by including each substance listed in Table 2 in the diluent. Among the combinations of fluorescent dyes used for fluorescent staining and other substances in other reagents, by selecting and using appropriate ones from the above substances, the fluorescence intensity difference between yeast-like fungi and erythrocytes increases. The discrimination between the two becomes more reliable.

  In each of the above embodiments, mention has been made of improving the fluorescent staining ability of yeast-like fungi to improve the accuracy of red blood cell discrimination. However, this technique is based on the fact that chained staphylococci are present in a specimen and thus discriminate red blood cells. The present invention can also be applied in the case of inhibiting. Since each staphylococcal cell is smaller than erythrocytes, it usually does not affect the discrimination of erythrocytes, but when staphylococci are linked, the apparent size increases and overlaps with the size of erythrocytes. Discrimination may be difficult. In such a case, red blood cells can be accurately discriminated by improving the fluorescent staining property of staphylococci using the reagents described above.

  Moreover, in the said Example, although urine is used as a test substance, this invention is not necessarily restricted to this. For example, cerebrospinal fluid, joint fluid, lymph fluid, pleural effusion, ascites, sputum, mucus such as pharyngeal mucus and nasal mucus, cleaning fluid such as tracheal lavage fluid, secretion such as urethral secretion and vaginal secretion, wound exudate and pus exudate The exudate may be used as a specimen.

DESCRIPTION OF SYMBOLS 100 Urine particle analyzer 200 Sample preparation part 221 Specimen setting part 222 Reagent setting part 223 Incubator 224 Dispensing apparatus 225 Specimen container 226 Reaction container 227 Reagent container 231 Reagent container 300 Detection part 301 Flow cell 306 Laser light source 308 Photodiode 311 Photomultiplier Plier tube 400 Control unit 401 Memory 402 CPU
403 Signal processing circuit 404 Operation control circuit

Claims (4)

A reagent for analyzing red blood cells in urine,
A first reagent comprising a nonionic organic compound having a benzene ring selected from the group consisting of benzyl alcohol, phenol, 1-phenoxy-2-propanol, 2-phenoxyethanol, phenyl acetate, 2-aminobenzothiazole and benzothiazole When,
A reagent for analysis of urine red blood cells , comprising a second reagent containing a fluorescent dye. The fluorescent dye has the following formula:

[Wherein, A is —O—, —S— or —C (CH 3) 2 —, R is a lower alkyl group, X is halogen, Y is —CH═ or —NH—, n is 0 or 1, and B is ,

(Wherein A and R are as defined above) or a phenyl group substituted with two lower alkoxy groups or one di-lower alkylamino group (this lower alkyl may be substituted with a cyano group). . The reagent for urine red blood cell analysis according to claim 1, which is selected from the group consisting of: The reagent for analyzing erythrocytes in urine according to claim 1 or 2 , wherein the first reagent has a pH in a range of 7.0 to 9.0. A reagent for analyzing red blood cells in urine,
A nonionic organic compound having a benzene ring selected from the group consisting of benzyl alcohol, phenol, 1-phenoxy-2-propanol, 2-phenoxyethanol, phenyl acetate, 2-aminobenzothiazole and benzothiazole, and a fluorescent dye, Reagent for urine red blood cell analysis.

Images